Pricing Log in Create free account

Cardiff Oncology, Inc. (CRDF) vs Gossamer Bio, Inc. (GOSS)

Cardiff Oncology, Inc. and Gossamer Bio, Inc. are both Biotechnology companies. Cardiff Oncology, Inc. and Gossamer Bio, Inc. are of similar size ($58.8M and $57.6M). Gossamer Bio, Inc. grew revenue faster over the last twelve months: 32.4% against −6.79%. Gossamer Bio, Inc. has the higher net margin (−235.0% vs −7,889.0%) and the higher return on invested capital (0.00% vs 0.00%). Across the 14 metrics below, Gossamer Bio, Inc. leads on 9 and Cardiff Oncology, Inc. on 5.

Valuation

Metric CRDF GOSS Biotechnology median
P/E n/m n/m 10.60
P/S 105.02 0.73 9.40
P/B 2.01 n/m 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m n/m 0.66
EV/Sales 39.84 4.07 9.02
Earnings yield (76.92%) (467.69%) (32.88%)
Free cash flow yield (76.74%) (417.17%) (23.13%)

Profitability

Metric CRDF GOSS Biotechnology median
Gross margin 100.00% 100.00% 68.51%
Operating margin (8,320.08%) (311.70%) 0.00%
Net margin (7,888.98%) (235.00%) 0.00%
Free cash flow margin (8,059.45%) (305.19%) 0.00%
Return on equity (94.14%) 178.72% (51.96%)
Return on assets (70.89%) (78.81%) (46.06%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric CRDF GOSS Biotechnology median
Revenue growth (TTM) (6.79%) 32.43% 6.76%
EPS growth (last fiscal year) 27.37% (200.00%) 29.88%
Revenue growth, 5-year CAGR 10.13% — 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric CRDF GOSS Biotechnology median
Debt to equity 0.00 (0.38) 0.00
Current ratio 3.30 0.53 4.97
Net debt to EBITDA 1.18 (0.35) 1.01

Dividend

Metric CRDF GOSS Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric CRDF GOSS Biotechnology median
Market cap 58.76m 57.56m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack